Clinical Trial Update: Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating chiglitazar sodium combined with venetoclax and azacitidine (CVA) for relapsed/refractory acute myeloid leukemia; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Chiglitazar sodium (chiglitazar)
• VIDAZA (AZACITIDINE)
• Venclyxto (Venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Acute Myeloid Leukemia, Relapse | Phase 1 | Status: RECRUITING